How the $2,000 Drug Cap Saves Medicare Retirees This Year
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Different volatility measures reveal different risk facets of stock indices. This primer clarifies what each metric means for decisions.
23,218 articlesMedicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
A State Street strategist says the Fed will cut rates three times in 2026, a view that clashes with current market pr...
Bitcoin has fallen out of step with broad money growth, creating a large gap between its price and M2-derived fair va...
As the Fed's path becomes less predictable, investors weigh how many rate cuts to expect in 2026. This guide breaks d...
Mortgage rates jump 6.5% this spring, reshaping affordability for buyers. As lenders adjust, borrowers weigh higher p...
A sweeping defense modernization plan totaling $185 billion could lift software-focused players like Palantir as miss...
Nvidia dominates AI GPUs, but Broadcom could offer a different path into AI growth. This article lays out three concr...
PayPal faced a liquidity cliff that could have erased the company. This report traces how a crisis, a bold offsite, a...
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
Ethereum has struggled to clear its late-2025 highs, with on-chain data showing a wave of whale selling even as ETF i...
Oil sits around $107.70 a barrel on May 11, 2026, supported by producer discipline and steady demand. The move could ...